Influencing factors and adverse outcomes of virologic rebound states in anti-retroviral-treated individuals with HIV infection.
Antiretroviral therapy
Blips
HIV/AIDS
Low-level viremia
Viral load
Virological failure
Virological rebound
Journal
Journal of virus eradication
ISSN: 2055-6640
Titre abrégé: J Virus Erad
Pays: England
ID NLM: 101654142
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
28
08
2022
revised:
01
03
2023
accepted:
03
03
2023
medline:
4
4
2023
entrez:
3
4
2023
pubmed:
4
4
2023
Statut:
epublish
Résumé
Antiretroviral therapy (ART) aims to inhibit HIV replication, decrease CD4 T cell loss, and immune function recovery in order to reduce the morbidity and mortality associated with the infection. Treatment should also, improve quality of life and control HIV spread. However, incomplete viral suppression still occurs during ART. Viral suppression and virological failure (VF) thresholds vary between studies in terms of virological rebound (VR) states using different detection thresholds. Further understanding of influencing factors and adverse outcomes in various VR states should provide important guidance for HIV treatment.
Identifiants
pubmed: 37008574
doi: 10.1016/j.jve.2023.100320
pii: S2055-6640(23)00006-7
pmc: PMC10063406
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100320Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
BMC Infect Dis. 2016 Jun 21;16:305
pubmed: 27329293
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):129-34
pubmed: 23018379
AIDS. 2014 Jan 14;28(2):181-186
pubmed: 24361679
AIDS. 2019 Nov 1;33(13):2005-2012
pubmed: 31306175
J Int AIDS Soc. 2014 Nov 02;17(4 Suppl 3):19668
pubmed: 25397418
AIDS. 2020 Aug 1;34(10):1519-1526
pubmed: 32675564
AIDS. 2002 May 3;16(7):1039-44
pubmed: 11953470
Antivir Ther. 2002 Dec;7(4):251-6
pubmed: 12553479
J Acquir Immune Defic Syndr. 2022 Apr 15;89(5):575-582
pubmed: 34966148
AIDS Res Hum Retroviruses. 2015 Oct;31(10):999-1008
pubmed: 26165150
J Nutr. 2000 May;130(5S Suppl):1421S-3S
pubmed: 10801954
PLoS One. 2015 Nov 13;10(11):e0142923
pubmed: 26566025
AIDS Care. 2021 Nov;33(11):1445-1450
pubmed: 32794406
AIDS. 2005 Jul 1;19(10):1065-9
pubmed: 15958838
J Antimicrob Chemother. 2021 Feb 11;76(3):722-728
pubmed: 33331635
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6632-6
pubmed: 1650477
Clin Infect Dis. 2019 Aug 16;69(5):805-812
pubmed: 30462188
HIV Med. 2017 Mar;18(3):196-203
pubmed: 27476742
Clin Infect Dis. 2021 Jun 15;72(12):2079-2086
pubmed: 32271361
Antivir Ther. 2008;13(7):927-36
pubmed: 19043927
HIV Med. 2022 Sep;23(8):825-836
pubmed: 35234328
J Virol. 2005 Aug;79(15):9625-34
pubmed: 16014925
AIDS. 2002 Aug 16;16(12):1627-32
pubmed: 12172084
J Infect Dis. 2010 May 1;201(9):1303-7
pubmed: 20350161
Clin Microbiol Infect. 2016 Dec;22(12):1004.e9-1004.e16
pubmed: 27585940
Antivir Ther. 2015;20(6):655-60
pubmed: 25735799
Open Forum Infect Dis. 2016 Jun 15;3(2):ofw089
pubmed: 27419163
JAMA. 2001 Jul 11;286(2):171-9
pubmed: 11448280
AIDS. 2002 Jul 26;16(11):1521-7
pubmed: 12131190
J Infect Dis. 2012 Apr 15;205(8):1230-8
pubmed: 22438396
J Glob Antimicrob Resist. 2022 Jun;29:7-16
pubmed: 35172201
HIV Med. 2022 Mar;23 Suppl 1:72-83
pubmed: 35293102
J Antimicrob Chemother. 2015 Aug;70(8):2347-53
pubmed: 25921516
J Virol. 2004 Oct;78(19):10566-73
pubmed: 15367623
J Infect Dis. 2011 Aug 15;204(4):515-20
pubmed: 21791652
Clin Infect Dis. 2019 Nov 27;69(12):2145-2152
pubmed: 30785191
AIDS. 2020 Aug 1;34(10):1559-1566
pubmed: 32675566
Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433
pubmed: 12617573
J Int AIDS Soc. 2020 Jul;23(7):e25550
pubmed: 32628816
J Clin Virol. 2005 May;33(1):75-8
pubmed: 15797369
J Antimicrob Chemother. 2014 Apr;69(4):1098-103
pubmed: 24335486
HIV Med. 2022 Mar;23 Suppl 1:64-71
pubmed: 35293103
BMC Infect Dis. 2020 Feb 17;20(1):147
pubmed: 32066392
Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2085-2092
pubmed: 28647858
J Antimicrob Chemother. 2016 Apr;71(4):1051-5
pubmed: 26702924
HIV Med. 2006 Oct;7(7):437-41
pubmed: 16925729
Antivir Ther. 2008;13 Suppl 2:1-13
pubmed: 18578063
J Clin Microbiol. 2013 May;51(5):1555-7
pubmed: 23390288
Pragmat Obs Res. 2017 May 26;8:91-97
pubmed: 28603436
AIDS. 2002 Sep 27;16(14):1967-9
pubmed: 12351960
J Clin Virol. 2020 Feb;123:104255
pubmed: 31927152
Int J Infect Dis. 2020 Feb;91:210-217
pubmed: 31821891
Antivir Ther. 2015;20(8):789-94
pubmed: 25945956
J Infect. 2005 Oct;51(3):195-200
pubmed: 16230215
J Infect Dis. 2007 Dec 15;196(12):1773-8
pubmed: 18190257
J Allergy Clin Immunol. 2008 Jul;122(1):22-8
pubmed: 18602567
J Antimicrob Chemother. 2008 Mar;61(3):699-704
pubmed: 18192682
AIDS Res Hum Retroviruses. 2013 Jan;29(1):68-76
pubmed: 23121249
J Antimicrob Chemother. 2012 Sep;67(9):2231-5
pubmed: 22643190
Microorganisms. 2021 Feb 15;9(2):
pubmed: 33671934
AIDS. 2015 Jan 28;29(3):373-83
pubmed: 25686685
Clin Infect Dis. 2013 Nov;57(10):1489-96
pubmed: 23946221
Lancet Infect Dis. 2018 Feb;18(2):188-197
pubmed: 29158101
Antimicrob Agents Chemother. 2012 Nov;56(11):5998-6000
pubmed: 22890763
AIDS Res Ther. 2016 Mar 22;13:16
pubmed: 27006682
J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):473-82
pubmed: 22481602
J Int AIDS Soc. 2014 Nov 02;17(4 Suppl 3):19828
pubmed: 25397572
Medicine (Baltimore). 2021 Sep 3;100(35):e26817
pubmed: 34477118
Antivir Ther. 2016;21(4):345-52
pubmed: 26756461
JAMA. 2005 Feb 16;293(7):817-29
pubmed: 15713771
J Int Assoc Physicians AIDS Care (Chic). 2011 Jan-Feb;10(1):54-6
pubmed: 21368016
Clin Infect Dis. 2020 Jun 10;70(12):2706-2709
pubmed: 31550044
Clin Infect Dis. 2012 Mar 1;54(5):724-32
pubmed: 22238167
Infect Drug Resist. 2021 Nov 02;14:4529-4537
pubmed: 34754201
BMC Infect Dis. 2021 May 18;21(1):448
pubmed: 34006230
AIDS. 2002 Mar 8;16(4):615-8
pubmed: 11873005
Clin Infect Dis. 2005 Nov 1;41(9):1326-32
pubmed: 16206110
Open Forum Infect Dis. 2015 Jan 14;2(1):ofu119
pubmed: 25884007
J Clin Microbiol. 2010 May;48(5):1911-2
pubmed: 20181895
MMWR Morb Mortal Wkly Rep. 2017 Jul 28;66(29):794
pubmed: 28749920
J Int Assoc Provid AIDS Care. 2020 Jan-Dec;19:2325958220979817
pubmed: 33372823
AIDS. 2002 Oct 18;16(15):2035-41
pubmed: 12370502
J Antimicrob Chemother. 2020 Oct 1;75(10):2981-2985
pubmed: 32642769
J Med Virol. 2013 Jun;85(6):953-8
pubmed: 23588720
PLoS One. 2012;7(5):e36673
pubmed: 22590588
J Int Assoc Provid AIDS Care. 2015 Jan-Feb;14(1):12-6
pubmed: 24651510
PLoS One. 2017 Jul 6;12(7):e0180761
pubmed: 28683128
J Antimicrob Chemother. 2022 Apr 27;77(5):1385-1395
pubmed: 35229102
J Mol Endocrinol. 2007 Jun;38(6):587-601
pubmed: 17556530
J Infect Dis. 2004 Apr 15;189(8):1487-96
pubmed: 15073687
BMC Infect Dis. 2015 Sep 21;15:382
pubmed: 26392270
J Clin Virol. 2020 Nov;132:104657
pubmed: 33049643
Indian J Sex Transm Dis AIDS. 2021 Jan-Jun;42(1):31-37
pubmed: 34765935
AIDS. 2004 Apr 30;18(7):981-9
pubmed: 15096800
PLoS One. 2014 Oct 29;9(10):e110749
pubmed: 25354368
Antivir Ther. 2015;20(2):165-75
pubmed: 24964403
Open Forum Infect Dis. 2021 Sep 17;8(9):ofab463
pubmed: 34584902
HIV Med. 2014 Aug;15(7):406-16
pubmed: 24460817
Int J Infect Dis. 2021 Apr;105:147-151
pubmed: 33592339
HIV Med. 2018 May;19(5):309-315
pubmed: 29493093